Travere Therapeutics is awaiting an FDA decision on a label expansion for FILSPARI in focal segmental glomerulosclerosis, a ...
Learn more about whether Relay Therapeutics, Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ ...
A year after revealing his “Liberation Day” trade policy initiatives, U.S. President Donald Trump is set to announce tariffs ...
You may be concerned about the recent declines in AI stocks such as NVDA.
View Praxis Precision Medicines, Inc. PRAX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results